C

Cannassure Therapeutics Ltd
TASE:CSURE

Watchlist Manager
Cannassure Therapeutics Ltd
TASE:CSURE
Watchlist
Price: 1 900 ILS 1.06% Market Closed
Updated: May 20, 2024
CSURE
/
Income Statement
/
Operating Income

Cannassure Therapeutics Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cannassure Therapeutics Ltd
Operating Income Peer Comparison

Comparables:
TEVA
TARO
I
INCR
MDWD
R
REKA

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Cannassure Therapeutics Ltd
TASE:CSURE
Operating Income
-₪2.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Operating Income
$3.6B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Operating Income
$22m
CAGR 3-Years
-49%
CAGR 5-Years
-40%
CAGR 10-Years
-25%
I
InterCure Ltd
TASE:INCR
Operating Income
₪34.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Operating Income
-$15.5m
CAGR 3-Years
-21%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Operating Income
₪2.9m
CAGR 3-Years
-48%
CAGR 5-Years
-29%
CAGR 10-Years
-17%

See Also

What is Cannassure Therapeutics Ltd's Operating Income?
Operating Income
-2.8m ILS

Based on the financial report for Dec 31, 2022, Cannassure Therapeutics Ltd's Operating Income amounts to -2.8m ILS.

What is Cannassure Therapeutics Ltd's Operating Income growth rate?
Operating Income CAGR 1Y
83%

Over the last year, the Operating Income growth was 83%.

ALPHA SPREAD
Join more than 139,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.